Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 21, 2024 18:06 ET | Source: Robbins LLP

AMLX Class Action Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline – April 9, 2024 – in Amylyx Pharmaceuticals, Inc. Class Action

Robbins LLP is investigating the allegations that Amylyx Pharmaceuticals, Inc. (AMLX) misled investors regarding RELYVRIO's commercial prospects.
March 05, 2024 16:16 ET | Source: Robbins LLP

AMLX STOCK NEWS: Lead Plaintiff Deadline is Approaching in Class Action Against Amylyx Pharmaceuticals, Inc.; Contact Robbins LLP for Information

Robbins LLP is Investigating the Allegations that Amylyx Pharmaceuticals, Inc. (AMLX) Misled Investors Regarding the Viability of its Drug for Treating ALS
February 20, 2024 15:18 ET | Source: Robbins LLP

AMLX Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in the Class Action Against Amylyx Pharmaceuticals, Inc.

Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals Inc.
February 12, 2024 22:28 ET | Source: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX)

Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals, Inc.